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INTRODUCTION 
Thyroid  nodules  are  very  commonly  observed  on  thyroid  
ultrasonography . Conventional  US has  been  widely  used  to  
determine  which  nodules  should  be  biopsied.  
Although  conventional  US  can  provide  meaningful  
information  in  thyroid  nodule  diagnosis,  there  has been considerable 
variation in diagnostic performances. 
According to the AmericanThyroidAssociation guidelines, no 
single US feature or combination  of features is adequately sensitive or 
specific to identify all malignant nodules [9]. For this reason, fine 
needle aspiration  cytology (FNAC) is  required for the nodules  with 
suspicious ultrasound signs . However, FNAC  has inherent limitations  
due to indeterminate and nondiagnostic results  
On  physical  examination,  a  hard  or  firm  nature  is  associated  
with  thyroid  malignancy.  But, palpation  is  very  subjective  and  
limited  in  patients  with  multinodular goiter  or  small  deep-seated 
nodules. As  a consequence, a significant number of patients eventually  
receive unnecessary thyroid surgery. 
Therefore, improvement  and refinement  of  noninvasive  
methods to depict malignancy  are needed.In this context, US 
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elastography (USE) has recently been introduced in the clinical workup 
of thyroid nodules. 
USE is a US-based technique to assess the biomechanical 
properties of tissue in the clinical setting . Meanwhile,  US-based  
elastography  can  provide  an  objective evaluation  of  tissue stiffnes. 
There  are  two  kinds  of  elastography  (strain  and  shear  wave  
elastography)  that  are currently  used  in  clinical  practice.  Among 
these types of USE, strain USE was the first to be introduced into 
commercially available systems. 
Although  many  reports  have  compared  conventional  US  with 
elastography,  in  clinical  practice,  the  final  decision  or  diagnosis  is  
usually  based  on  a  combination of  conventional  US  and  
elastography.  
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EMBRYOLOGY 
Thyroid is a butterfly-shaped gland situiated in the neck deep to 
the strap muscle. It develops as an evagination of the primitive foregut 
at the level of foramen cecum in the base of tongue.  
Endodermal cells at the floor of the primitive foregut start to 
thicken and form the median primordium(bud) of the thyroid, which 
descends anterior to the structures forming the laryngx. An epithelium-
lined thyroglossal duct connects the foramen cecum and the median 
primordium . 
The cells from the median primordium  become thyroid hormone 
producing follicular cells. The paired lateral primordium(bud)s develop 
from the fourth pharyngeal pouches and fuse the median primordium , 
forming ultimobranchial bodies. The neuroectodermal lateral 
primordium (ultimobranchial bodies) provide the parafollicular C cells 
producing calcitonin. 
  ANATOMY:
1,2 
The bilateral thyroid lobe is connected with each other by the 
midline isthmus. 
A pyramidal lobe can arise from the isthmus in 50% of patients.  
The pyramidal lobe can extend up to the level of the hyoid bone.  
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FIG 1. Early development of  thyroid gland.The epithelium lined 
median primordium (c) fuse with the neuroectodermal lateral  
primordium(ultimobranchhial bodies, F), formig the thyroid gland.The  
ultimobranchial bodies provide the parafolllicular c cells producing 
calcitonin. 
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Notes: III, third branchial pouch; four branchial pouch;A, foramen 
caecum; B thyroglossal duct; C ,median thyroid;D,inferior parathyroid; 
E, superior parathyroid ;F,ultimobranchial body; G,thymus; Tr,trachea; 
Eso,esophagus 
RELATIONS: 
The thyroid gland is anterior to the prevertebral and paraspinal 
musculature and deep to the sternothyroid and sternohyoid muscles.  
ARTERIAL  SUPPLY: 
The thyroid gland has a rich blood supply, derived from the 
superior, inferior, and the small inferior ima arteries that often directly 
originate from the aortic arch.  
VENOUS DRAINAGE: 
Venous drainage   is via multiple surface veins draining into the 
superior, middle, and inferior thyroid veins.  
PHYSIOLOGY: 
Thyroid gland produces 2 types of thyroid hormones:  thyroxine 
(T4) and triiodothyronine (T3), which are iodinated derivat ives of 
tyrosine. The primary internal regulation of thyroid activity is through 
the anterior pituitary gland secreting thyroid-stimulating hormone by 
way of thyrotropin-releasing hormone released by the hypothalamus.  
Most circulating thyroid hormones are bound to plasma proteins; the 
most important and dominant of which is thyroglobulin (Tg).  
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Fig -2: Thyroid gland is highly vascular . It is supplied by superior 
and inferior thyroid arteries .It is drained via superior ,middle and 
inferior thyroid veins . 
 
Fig-3: Lymphatic drainage of thyroid 
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HISTOLOGY 
 
FIG.7.Lobule of thyroid 
 
 DISTINGUISING FEATURES OF THYROID 
 Follicle is a structural unit. 
 Follicle contains follicular epithelial cells and parafollicular cells.  
 Follicle shows follicular cavity in which contains gel-like colloid. 
 Inter-follicular spaces are filled by reticular connective tissue and 
blood vessels. 
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FIG.8: follicles and Colloid of thyroid gland 
 
COLLOID 
 Cavity of thyroid follicle is filled with semi –fluid or gel like 
substance, called thyroid colloid 
 the endocrine secretion of epithelia cells and composed of 
nucleoproteins, thyroglobulin and proteolytic enzymes.  
 Among the endocrine glands, thyroid is unique because it 
utiloizes an inorganic element iodine for the synthesis of its 
hormone. 
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FIG. 9: Follicular cells of thyroid gland 
 
FOLLICULAR CELLS 
 These are cuboidal epithelial cells with their basal ends resting on 
basement membrane. 
 These cells show the changes in shape  depending on state of 
gland. 
 When the gland is inactive, cells exhibit squamous structure and 
columnar when hyperactive. 
 The follicular cells show central or basal round nucleus with one 
or more eccentric nuclei. 
 The apical tips of cells extend microvilli in the cavity.  
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CROSS SECTIONAL ANATOMY
3
 
  
FIG 10, Transverse sonogram  made with 7.5-MHz linear array 
transducer Tr, tracheal air shadow; C, common carotid artery; J, 
jugular vein. 
 
FIG .7, Relations of thyroid gland 
IMAGING MODALITIES  
Imaging modalities for the thyroid gland include cross-sectional 
imaging techniques, such as ultrasound (US), computed tomography 
(CT), magnetic resonance imaging (MRI), or positron emission 
tomography (PET) and  nuclear scintigraphy .  
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Ultrasound  is the most frequently performed examination for 
thyroid lesions . US plays a pivotal role in the diagnosis and 
management of benign and malignant thyroid nodules.  
US allows characterization of thyroid nodules, detection of cervical 
lymphadenopathy, and guidance for FNA as well as percutaneous intervention, 
such as ethanol, radio frequency, or laser ablation. 
American Thyroid Association recommended in the revised 
guidelines on 2009 that thyroid US should be performed in patients with 
palpable or incidental thyroid nodules on CT, MRI, or 
18fluorodeoxyglucose (FDG)-PET scan. 
THYROID USG TECHNIQUE : 
Thyroid US should be performed with high-frequency linear 
probes ranging from 7 to 12 MHz. 
Patients are in supine position with hyperextension of the neck. 
Scanning field includes the central neck from the lower border of the 
mandible to the sternal notch and the bilateral cervical nodal chains and 
the supraclavicular area, to detect accompanying nodal metastasis from 
thyroid cancer. 
The thyroid gland should be evaluated in both transverse and 
longitudinal scans for each individual lobe and isthmic lobe separately. 
US features, such as contents, margins, shapes, macro-or 
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microcalcifications, and echogenicity in combination, are used to access 
the malignant potential of each lesion. When a thyroid nodule is 
detected by US, the size in its maximum dimension should be recorded 
for the management and follow-up reference. Although malignancy risk 
becomes 4 times higher in the nodules equal to or 4 cm than that of 
smaller ones, size is not an independent predictor for malignancy. 
Smaller nodules could have as much risk of malignancy as larger 
nodules. 
COMPUTED TOMOGRAPHY/ MAGNETIC RESONANCE 
IMAGING: 
CT and MR imaging provide important information about the 
extension of thyroid disease into adjacent structures, including the 
trachea and larynx, esophagus, and great vessels. 
CT or MRI has a complimentary role with US in preoperative 
staging and postoperative surveillance of thyroid cancer, and evaluation 
of mediastinal goiter or ectopic thyroid. CT is also helpful in the 
evaluation of nodal status of thyroid cancer, especially in US-
inaccessible area (retropharyngeal space or mediastinum). MRI is 
preferred to CT in the evaluation of the extent of thyroid neoplasm due 
to superior soft-tissue contrast. MR does not require iodinated contrast 
agent, which is advantageous for patients planned for radioactive iodine 
(RAI) imaging or therapy. 
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APPROACH TO THYROID LESIONS:
4 
Thyroid  lesions  are  classified  into  diffuse  and  nodular  
thyroid lesions. 
Several thyroid diseases are characterized by diffuse  rather than 
focal involvement. 
This usually results in  generalized enlargement of the gland 
(goiter) and no palpable nodules. Specific conditions that produce such 
diffuse enlargement include chronic autoimmune lymphocytic 
thyroiditis (Hashimoto’s thyroiditis), colloid or adenomatous goiter, and 
Graves’ disease. 
These conditions are usually diagnosed on the basis of clinical 
and  laboratory findings and occasionally by  FNA biopsy. Sonography 
is seldom indicated. However, high-resolution  sonography can be 
helpful when the underlying  diffuse  disease causes asymmetrical 
thyroid enlargement, which suggests a mass in the larger lobe. The 
sonographic  finding of generalized parenchymal abnormality may alert 
the clinician to consider diffuse thyroid disease as the underlying cause. 
FNA, with sonographic guidance if necessary, can be performed if a 
nodule is detected. 
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DIFFUSE THYROID LESIONS – SONOGRAPHIC 
EVALUATION 
Recognition of diffuse thyroid enlargement on sonography can 
often be facilitated by noting the thickness of  the isthmus, normally a 
thin bridge of tissue measuring  only a few millimeters in AP dimension. 
With diffuse  thyroid enlargement, the isthmus may be up to 1 cm or  
more in thickness. 
DIFFUSE THYROID DISEASES:
39,40 
Acute suppurative thyroiditis 
Subacute granulomatous thyroiditis 
Hashimoto’s thyroiditis (chronic lymphocytic  thyroiditis)  
Adenomatous or colloid goiter 
Painless (silent) thyroiditis  
Acute suppurative thyroiditis is a rare  inflammatory disease 
usually caused by bacterial infection and affecting children. Sonography 
can be useful in select patients to detect the development of a frank 
thyroid abscess. The infection usually begins in the perithyroidal  soft 
tissues. On ultrasound images, an abscess  is seen as a poorly defined, 
hypoechoic heterogeneousmass with internal debris, with or without 
septa and gas. Adjacent inflammatory nodes are often present.  
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Subacute granulomatous thyroiditis or de Quervain’s   
disease,
40,41
 is a spontaneously remitting inflammatory  disease probably 
caused by viral infection.  Sonographically, the gland may appear 
enlarged and hypoechoic, with normal or decreased vascularity caused 
by diffuse edema of the gland, or the process may appear as focal 
hypoechoic regions. Although usually not necessary, sonography can be 
usto assess evolution of de Quervain’s disease after medical therapy.  
 
Fig 11. Focal areas of subacute thyroiditis.  Longitudinal power 
Doppler image of the  thyroid gland shows two poorly defined 
hypoechoic areas(arrow) caused by subacute thyroiditis .  
 
The most common type of thyroiditis is chronic autoimmune  
lymphocytic thyroiditis, or Hashimoto’s  thyroiditis. It typically 
occurs as a painless, diffuse enlargement of the thyroid gland in a young 
or middleaged woman, often associated with hypothyroidism. The 
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typical sonographic appearance of Hashimoto’s thyroiditis is diffuse, 
coarsened, parenchymal   echotexture, generally more hypoechoic than a 
normal thyroid. 
In most cases the gland  is enlarged. Multiple, discrete hypoechoic 
micronodules from 1 to 6 mm in diameter are strongly suggestive  of 
chronic thyroiditis; this appearance has been called   micronodulation
43
 . 
Micronodulation is a highly sensitive sign of chronic thyroiditis . 
micronodules represent lobules of thyroid parenchyma  that have been 
infiltrated by lymphocytes and    plasma cells. 
 
Fig 12. Hashimoto’s thyroiditis: coarse septations.  
These lobules are surrounded by multiple  linear echogenic 
fibrous septations . These fibrotic septations may give the parenchyma a 
“pseudolobulated”  appearance. Both benign and malignant  thyroid 
nodules may coexist with chronic lymphocytic  thyroiditis, and FNA is 
often necessary to establish the final diagnosis.. As with other  
 17 
autoimmune disorders, there is an increased risk of  malignancy, with a 
B-cell malignant lymphoma most   often arising within the gland.  
Although the appearance of diffuse parenchymal  inhomogeneity 
and micronodularity is typical of Hashimoto’s  thyroiditis, other diffuse 
thyroid diseases, most frequently multinodular or adenomatous goiter, 
may  have a similar sonographic appearance.
44
 Most patients  with 
adenomatous goiter have multiple discrete nodules  separated by 
otherwise normal-appearing thyroid parenchyma.  others have 
enlargement with  rounding of the poles of the gland, diffuse 
parenchymal  inhomogeneity, and no recognizable normal tissue. 
Adenomatous  goiter affects women three times more often  than men.  
Graves’ disease45 is a common diffuse abnormality of   the 
thyroid gland and is usually biochemically characterized  by 
hyperfunction (thyrotoxicosis). The echotexture  may be more 
inhomogeneous than in diffuse goiter,  mainly because of numerous 
large, intraparenchymal  vessels. Further, especially in young patients, 
the parenchyma  may be diffusely hypoechoic because of the extensive   
lymphocytic infiltration or the predominantly cellular content of the 
parenchyma, which becomes  almost devoid of  colloid substance. Color 
Doppler sonography often demonstrates a hypervascular pattern  
referred to as the thyroid inferno. Spectral Doppler will often 
demonstrate peak systolic velocities exceeding 70 cm/sec, which is the 
highest velocity found in thyroid diseases. A significant decrease in  
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flow velocities in the superior and inferior thyroid arteries after medical 
treatment has been reported. 
The rarest type of inflammatory thyroid disease is  invasive 
fibrous thyroiditis, also called Riedel’s   struma. This disease 
primarily affects women and  often progresses to complete destruction 
of the gland. 
Some cases may be associated with mediastinal or retroperitoneal  
fibrosis or sclerosing  cholangitis.  The primary  reason for sonography is 
to check for extrathyroid extension of the inflammatory process, with 
encasement of the  adjacent vessels . Such information can be particularly 
useful in surgical planning. Open biopsy is generally required to 
distinguish this condition from  anaplastic thyroid carcinoma. The 
sonographic findings  in these two  diseases may be identical.  
 
Fig 13.Transverse color Doppler image  of the left lobe shows 
increased vascularity, indicating an acute   stage of the Graves’ 
disease process; Tr, trachea 
 
 19 
NODULAR   THYROID   LESIONS : 
Many  thyroid  diseases  can  present  clinically  with  one  or more  
thyroid  nodules.  Such  nodules  represent  common and  controversial  
clinical  problems.  women affected  more  frequently  than  men. Exposure  
to  ionizing  radiation  increases  the  incidence  of  benign  and malignant  
nodules,  with  20%  to  30%  of  a  radiationexposed  population  having  
palpable  thyroid  disease. Although nodular thyroid disease is relatively  
common, thyroid  cancer  is  rare  and  accounts  for  less  than  1%  of all  
malignant  neoplasms.  The   majority of  thyroid  nodules  are  benign.  The  
clinical  challenge  is to  distinguish  the  few  clinically  significant  
malignant nodules  from  the  many  benign  nodules  and  thus  identify 
patients  who  need  surgical  excision.  This  task  is  complicated  because  
nodular  disease  of  the  thyroid  gland often  is  clinically  occult  (<10-15  
mm),  although  it can  be  readily  detected  by  high-resolution  sonography. 
HYPERPLASIA  AND  GOITER: 
Approximately 80% of nodular thyroid disease is caused  by 
hyperplasia
5,6
 of the gland and occurs in up to 5% of  any population. 
Its etiology includes iodine deficiency  (endemic),  disorders of 
hormonogenesis (hereditary familial forms), and poor utilization of 
iodine as a  result of medication. When hyperplasia leads to an  overall 
increase in size or volume of the gland, the term  goiter is used. The 
peak age of patients with goiter is 35 to 50 years, and women are 
affected three times more  often than men
7
. 
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Sonographically, most hyperplastic or adenomatous   nodules are 
isoechoic compared to normal thyroid tissue  , but may become 
hyperechoic because of the numerous interfaces between cells and 
colloid  substance
8
 . Less frequently, a  hypoechoic spongelike or 
honeycomb pattern is seen . When the nodule is isoechoic  or 
hyperechoic, a thin peripheral hypoechoic halo is  typically seen, most 
likely caused by perinodular blood   vessels and   mild edema or 
compression of the adjacent  normal parenchyma. Perinodular blood 
vessels are typically   detected by color Doppler sonogram
9,10
. 
Histologically, the initial stage is cellular hyperplasia   of the 
thyroid acini, followed by micronodule and  macronodule   formation, 
often indistinguishable from  normal thyroid parenchyma, even at 
histology. Hyperplastic   nodules often undergo liquefactive degeneration  
with the accumulation of blood, serous fluid, and   colloid substance
11
. 
 
Fig 14. Three hyperechoic nodules,  typical of hyperplasia.  
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Pathologically, they are often referred to as hyperplastic, 
adenomatous,   or colloid nodules. Many (if not all) cystic  thyroid 
lesions are hyperplastic nodules that have undergone  extensive 
liquefactive degeneration. Pathologically, true epithelial -lined cysts of 
the thyroid gland are rare. 
In the course of this cystic degenerative process, calcification,  
which is often coarse and perinodular, may occur. Hyperplastic nodule 
function may have  decreased, may have remained normal, or may have   
increased (toxic nodules).  
Hyperfunctioning   (autonomous) nodules often exhibit an 
abundant perinodular  and intranodular vascularity; however, because    
of the hypervascular pattern shown in most solid thyroid    nodules on 
high-sensitivity Doppler systems, this feature   does not allow detection 
of hyperfunctioning nodules   within multinodular goiters with 
sonography.
9,10
 
The degenerative changes of goitrous nodules correspond  to their 
sonographic appearances .  Purely anechoic areas are caused by serous 
or colloid  fluid. Echogenic fluid or moving fluid-fluid levels 
correspond to hemorrhage.
11
 Bright echogenic foci  with comet-tail 
artifacts are likely caused by microcrystals  or aggregates of colloid 
substance, which may also  move slowly, like snowflakes, within the 
fluid collection. 
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Thin, intracystic septations probably correspond  to attenuated 
strands of thyroid tissue and appear  completely  avascular on  color 
Doppler ultrasound. These  degenerative processes may also lead to the 
formation of  calcifications, which may be either thin, peripheral  
shells (“eggshell”) or coarse, highly reflective foci with  associated 
acoustic shadows, scattered throughout the  gland. 
ADENOMA
1   
Adenomas represent only 5% to 10% of all nodular disease  of the 
thyroid and are seven times more common in  women than me5 .  Most  
result  in no thyroid dysfunction. 
Most adenomas are solitary, but  may also develop as part of a 
multinodular process. The benign follicular adenoma is a true thyroid  
neoplasm, characterized by compression of adjacent  tissues and fibrous 
encapsulation. 
Various subtypes of follicular adenoma include the fetal 
adenoma, Hürthle cell adenoma, and embryonal adenoma, each 
distinguished  according to the type of cell proliferation. The cytologic 
features of follicular adenomas are generally  indistinguishable from 
those of follicular carcinoma. 
Vascular and capsular invasion are the hallmarks of follicular  
carcinoma, identified by histologic rather than  cytologic analysis. 
Therefore, such tumors are usually surgically removed.  
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Sonographically, adenomas are usually solid masses  that may be 
hyperechoic, isoechoic, or hypoechoic . They often have a thick, smooth  
peripheral hypoechoic halo resulting from the fibrous  capsule and blood 
vessels, which can be readily seen by  color Doppler imaging. Often, 
vessels pass from the   periphery to the central regions of the nodule, 
sometimes  creating a “spoke and wheel”  appearance. This vascular  
pattern is usually seen in both hyperfunctioning and   poorly functioning 
adenomas and thus does not allow   the detection of hyperfunctioning 
lesions. 
 
Fig 15. homogeneous, hypoechoic, round to oval masses with a  
surrounding thin halo, the capsule   of the adenoma; Tr, tracheal air 
 shadow; C, carotid artery. 
CARCINOMA: 
Most primary thyroid cancers are of epithelial origin  and are 
derived from follicular or parafollicular cells. . Malignant thyroid tumors 
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of mesenchymal origin are  exceedingly rare, as are metastases to the 
thyroid. 
Most  thyroid cancers are well differentiated, and papillary  
carcinoma (including so-called mixed papillary and follicular  
carcinoma) accounts for 75% to 90% of all cases.  In contrast, medullary, 
follicular, and anaplastic  carcinomas (combined) represent only 10% to 
25%  of all thyroid carcinomas. 
PAPILLARY CARCINOMA OF THYROID:  
Although it can  occur in patients of any age, prevalence of 
papillary  thyroid carcinoma peaks in both the third and the seventh 
decade of life.
12
 Women are affected more often than men. On 
microscopic examination, the tumor is  multicentric within the thyroid 
gland in at least 20% of  cases
14
. Round, laminated calcifications 
(psammoma  bodies) in the cytoplasm of papillary cancer cells are seen  
in approximately 35% of patients. The major route of  spread of 
papillary carcinoma is through the lymphatics to   nearby cervical lymph 
nodes. 
In fact, a patient  with papillary thyroid cancer may present with 
enlarged   cervical nodes and a palpably normal thyroid gland.
17
  
Interestingly, the presence of nodal metastasis in the   neck generally 
does not appear to worsen the prognosis   for this malignancy. Distant 
metastases are very rare  (2%-3%) and occur mostly in the mediastinum 
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and  lung  . After 20 years, the cumulative mortality from papillary    
thyroid cancer is typically only 4% to 8%. 
 Sonographic characteristics   of papillary carcinoma  are relatively   
distinctive, as follows ; 
 Hypoechogenicity (90% of cases), resulting from   closely packed 
cell content, with minimal colloidsubstance.  
 Microcalcifications, appearing as tiny, punctuate   hyperechoic 
foci, either with or without acoustic  shadows . In rare, but  
usually aggressive cases of papillary carcinomas of  childhood, 
microcalcifications may be the only  sonographic sign of the 
neoplasm, even without  evidence of a nodular lesion. . 
 Hypervascularity (90% of cases), with disorganized  vascularity, 
mostly in well-encapsulated forms. 
 Cervical lymph node metastases, which may  contain tiny, 
punctate echogenic foci caused by  microcalcifications . These are 
mainly  located in the caudal half of the deep jugular chain.  
Occasionally, metastatic nodes may be cystic as a   result of 
extensive degeneration . Cystic nodal metastases show a thickened outer   
wall, internal nodularity, and septations in most cases,   although they 
may appear purely cystic in younger   patients.  Cystic lymph node 
metastases in the neck   occur almost exclusively in association with 
papillary  thyroid carcinoma, but occasionally with nasopharyngeal   
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carcinomas.   The overwhelming majority of papillary carcinomas   
appear as a predominantly solid mass. 
Invasion   of  adjacent muscles is infrequently visualized by 
ultrasound   but indicates that the mass is malignant. . A follicular 
variant accounts for 10% of cases of  papillary carcinoma and appears 
similar to a follicular  neoplasm on gross pathologic inspection and 
ultrasound. 
Papillary microcarcinoma is a rare, nonencapsulated   sclerosing 
tumor measuring 1 cm or less in diameter . Most patient (80%) present 
with enlarged cervical   nodes and a palpably normal thyroid gland.
17
 
Papillary  microcarcinoma  can be imaged by high-frequency ultrasound. 
 
Fig 16.hypoechoic nodules that contain echogenic foci caused by  
microcalcification; 
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FOLLICULAR CARCINOMA :
16 
Follicular carcinoma is the  second subtype of well-differentiated 
thyroid cancer. It   accounts for 5% to 15% of all cases of thyroid 
cancer, affecting women more often than men.  The two variants of 
follicular carcinoma differ greatly in histology and clinical course.  The 
minimally invasive follicular carcinomas are encapsulated, and only the 
histologic demonstration of focal invasion of capsular blood vessels of 
the fibrous capsule itself permits differentiation from follicular 
adenoma. 
 
Fig 17. Power Doppler image shows that nodule is hypervascular  and 
 has flow in the center and at the periphery.  
The widely invasive follicular carcinomas are not well 
encapsulated, and invasion of  the vessels and the adjacent thyroid is 
more easily demonstrated. Both variants of follicular carcinoma tend to  
spread through the bloodstream rather than the lymphatics, and distant 
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metastases to bone, lung, brain, andliver are more likely than metastases 
to cervical lymphnodes. 
No unique sonographic features allow differentiation of follicular 
carcinoma from adenoma, which is not surprising,  given the cytologic 
and histologic similarities ofthese two tumors . Similarly, fine-needle 
aspiration is not reliable in differentiating  benign from malignant 
follicular neoplasms because the  pathologic diagnosis is not based on 
cellular appearance but rather on capsular and vascular invasion. 
Therefore, most follicular nodules must be surgically removed for  
accurate pathologic diagnosis. Features that suggest follicular  
carcinoma are rarely seen but include irregular tumor margins, a thick 
irregular halo, and a tortuous or chaotic arrangement of internal blood 
vessels on color   Doppler imaging. 
FOLLICULAR THYROID CARCINOMA 
SONOGRAPHIC FEATURES: 
 Irregular tumor margins 
 Thick, irregular halo 
 Tortuous or chaotic arrangement of internal blood Vessel  
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Fig 18 A, Left lobe, and18 B, right lobe, of the   thyroid show round, 
homogeneous hypoechoic masses that appear identical except for size 
differences on transverse images; Tr, tracheal air shadow. The smaller 
mass was malignant and the larger mass benign 
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Fig 19.  Microscopic appearance of the capsule shows invasion of the   
follicular  cells into the capsule (arrows). This is one of the  
microscopic features that allows a pathologic diagnosis of    
malignancy but is not visible by ultrasound    .                         
MEDULLARY CARCINOMA: 
Medullary carcinoma accounts   for about 5% of all malignant 
thyroid diseases. It is derived from the parafollicular cells, or C cells, 
and typically secretes the hormone calcitonin, which can be  a useful 
serum marker. This cancer is frequently familial(20%) and is an 
essential component of the multiple  endocrine neoplasia (MEN) type 
II syndromes. The  disease is multicentric and/or bilateral in about 90% 
of the familial cases . There is a high incidence of metastatic 
involvement of lymph nodes. The   prognosis for patients with 
medullary cancer is somewhat  worse than for follicular cancer. 
The sonographic appearance of medullary carcinoma  is usually 
similar to that of papillary carcinoma and is seen most often as a 
hypoechoic solid mass. Calcifications   are often seen (histologically 
caused by calcified nests of amyloid substance) and tend to be more 
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coarse than the calcifications of typical papillary carcinoma.  
Calcifications can be seen not only in the primary tumor but also in 
lymph node metastases and    even in hepatic metastases.  
 
Fig 20.Transverse dual image in patient with multiple endocrine 
neoplasia type II (MEN II) shows bilateral hypoechoic masses 
(arrows) that contain areas of coarse calcification; C, carotid arteries;  
Tr, trachea; E, esophagus. 
ANAPLASTIC THYROID CARCINOMA. 
15 
Anaplastic thyroid  carcinoma is typically a disease of elderly 
persons; it represent one of the most lethal of solid tumors. Although it 
accounts for less than 2% of all thyroid cancers, it carries the worst 
prognosis, with a 5-year mortality rate of more than 95%. The tumor 
typically presents as a rapidly enlarging mass extending beyond the 
gland and  invading adjacent structures. It is often inoperable at 
presentation. Anaplastic carcinomas may often be associated  with 
papillary or follicular carcinomas, presumably representing a 
dedifferentiation of the neoplasm. They tend not to spread via the 
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lymphatics but instead are prone to aggressive local invasion of muscles 
and vessels. 
Sonographically, anaplastic thyroid carcinomas are usually 
hypoechoic and often encase or invade bloodvessels and neck muscles . 
Often these tumors cannot be adequately examined by ultrasound 
because of their large size. Instead, computed tomography (CT) or 
magnetic resonance imaging (MRI) of the  neck usually demonstrates 
the extent of disease more  accurately.  
ANAPLASTIC THYROID CARCINOMA: 
SONOGRAPHIC FEATURES 
 Large, hypoechoic mass 
 Encase or invade blood vessels 
 Invade neck muscles 
 
LYMPHOMA
18 
Lymphoma accounts for approximately 4% of all thyroid 
malignancies. It is mostly of the non-Hodgkin’s type andusually affects 
older women. The typical clinical sign is 
a rapidly growing mass that may cause symptoms of  obstruction 
such as dyspnea and dysphagia. In 70% to    80% of patients, lymphoma 
arises from a preexisting chronic lymphocytic thyroiditis (Hashimoto’s 
thyroiditis)  with subclinical or overt hypothyroidism. The prognosis is 
highly variable and depends on the stage of the disease. Five-year 
 33 
survival ranges from almost 90% in  early-stage cases to less than 5% in 
advanced, disseminated disease. 
Sonographically, lymphoma of the thyroid appears as  an 
extremely hypoechoic and lobulated mass. Large areas of cystic necrosis 
may occur, as well as encasement of adjacent neck vessels. On color 
Doppler imaging, both nodular and diffuse thyroid lymphomas  may 
appear mostly hypovascular or may show blood, vessels with chaotic 
distribution and AV shunts. The adjacent thyroid parenchyma may be 
heterogeneous as a    result of associated chronic thyroiditis.  
 
Fig21. Transverse image of left lobe of the thyroid shows diffuse mass 
enlarging the lobe and extending into the soft tissues (arrows) 
surrounding the common carotid artery (c); Tr, tracheal air shadow. 
THYROID METASTASES: 
Metastases to the thyroid are infrequent, occurring late  in the 
course of neoplastic diseases as the result of hematogenous  spread or 
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less frequently a lymphatic route.   Metastases usually are from 
melanoma (39%), breast   (21%), and renal cell (10%) carcinoma. 
Metastases   may appear as solitary, well-circumscribed nodules 
or as diffuse involvement of the gland. On sonography,   thyroid tumors 
are solid, homogeneously hypoechoic  masses, without calcifications . 
         
 
Fig 22.  images show a 1-cm solid  mass representing proven thyroid 
metastasis from renal cell carcinoma. 
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NODULAR  THYROID  DISEASE: 
SONOGRAPHIC  EVALUATION 
 Determine  location  of  palpable  neck  mass  (e.g., thyroid  or  
extrathyroid).  
 Characterize  benign  versus  malignant  nodule features.  
 Detect  occult  nodule  in  patient  with  history  of  head and  
neck  irradiation  or  MEN  II  syndrome.  
 Determine  extent  of  known  thyroid  malignancy.  
 Detect  residual,  recurrent,  or  metastatic  carcinoma.  
 Guide  fine-needle  aspiration  of  thyroid  nodule  or cervical  
lymph  nodes. 
The  fundamental  anatomic  features  of  a  thyroid nodule  on  high-
resolution  sonography  are  as  follows: 
 Internal  consistency  (solid,  mixed  solid  and  cystic,  or purely  
cystic) 
 Echogenicity  relative  to  adjacent  thyroid  parenchyma 
 Margin 
 Shape 
 Presence  and  pattern  of  calcification 
 Peripheral  sonolucent  halo 
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 Presence  and  distribution  of  blood  flow  signals  
INTERNAL  CONTENTS : 
Usually, approximately 70%  of  thyroid  nodules  are  solid,  
whereas  the  remaining 30%  exhibit  various  amounts  of  cystic  
change.  A  nodule that  has  a  significant  cystic  component  is  
usually  a benign  adenomatous  (colloid)  nodule  that  has undergone  
degeneration  or  hemorrhage. 
All  cystic  thyroid  lesions seen  with  high-resolution  ultrasound  
demonstrate  some wall  irregularity  and  internal  solid  elements  or  
debris  caused  by  nodule  degeneration.  
. 
Fig 23. honeycomb-like or cystic changes, with nodules  showing   
larger cystic spaces  indicate a very high  probability of a benign 
process 
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Fig 24.Typical appearance of colloid cysts.  Nodules that are mostly 
cystic are considered benign. These  nodules have tiny echogenic foci 
that are thought to be microcrystals. A few of these foci are associated 
with  comet-tail artifacts . 
Comet-tail  artifacts  are  frequently  encountered  in cystic  
thyroid  nodules  and  are  likely  related  to  the  presence  of  
microcrystals  .  These  comet-tail  arti- facts  can be  located  in  the  
cyst  walls  and  internal  septations  or  in  the  cyst  fluid  . 
When  a  more  densely  echogenic fluid  is  gravitationally  
layered  in  the  posterior  portion  of a  cystic  cavity,  the  likelihood  
of  hemorrhagic  debris  is very  high.  Frequently,  patients  with  
hemorrhagic  debris present  clinically  with  a  rapidly  growing,  often  
tender neck  mass.  The  spongiform  appearance  of  thyroid nodules,  
related  to  the  presence  of  tiny  colloid  changes, is  an  extremely  
uncommon  finding  in  malignant  nodules, particularly  when  it  is  
associated  with  other  findings  such as  well-defined  margins  and  
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isoechogenicity.  This  pattern is  highly  predictive  of  a  benign  
nodule  . Papillary  carcinomas  may  rarely  exhibit  varying amounts  
of  cystic  change  and  appear  almost  indistinguishable  from  benign  
cystic  nodules. In  cystic  papillary  carcinomas,    the  frequent  
sonographic detection  of  a  solid  elements  or  projections  (≥1  cm  
with blood  flow  signals  and/or  microcalcifications)  into  the lumen  
can  lead  to  suspicion  of  malignancy  .  Cervical  metastatic  lymph  
nodes  from  either  a solid  or  a  cystic  primary  papillary  cancer  may  
also  demonstrate  a  cystic  pattern;  this  is  likely  pathognomonic  of 
malignant  adenopathy. 
SHAPE: 
A  taller-than-wide  shape,  in  which  the  AP  diameter  is  equal  
or  less  than  its  transverse  diameter  on  a transverse  or  longitudinal  
plane,  is  specific  for  differentiating  malignant  nodules  from  benign  
nodules,   because  malignant  neoplasms  (taller  than  wide)  grow 
across  normal  tissue  planes,  whereas  benign  nodules grow  parallel  
to  normal  tissue  planes. 
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Fig 25.  Hyperplastic nodule. 
Oval homogeneous nodule – follicular adenoma. 
ECHOGENICITY : 
Thyroid  cancers  are  usually  hypoechoic relative  to  the  
adjacent  normal  thyroid  parenchyma  .   Many  benign  thyroid 
nodules  are  also  hypoechoic.  Marked  hypoechogenicity  is  highly 
specific  for  diagnosing  malignant  nodules,  whereas  the  
hypoechogenicity  often  found  in  benign  lesions  is  usually less  
marked. A  predominantly  hyperechoic  nodule, although  relatively  
uncommon,  is  more  likely  to  be benign.  The  isoechoic  nodule,  
visible  because  of  a peripheral  sonolucent  rim  that  separates  it  
from  the  adjacent  normal  parenchyma,  has  an  intermediate  to  low  
risk of  malignancy.  Isoechogenicity  has  low  sensitivity  but high  
specificity  and  positive  predictive  value  for  the  diagnosis  of  
benign  nodules . 
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Fig 26. Solitary hyperechoic nodule, which was  benign on fine-needle 
aspiration biopsy 
HALO : 
A  peripheral  sonolucent  halo  that  completely  or incompletely  
surrounds  a  hypoechogenicity  often  found  in  benign  lesions  is  
usually less  marked. A  predominantly  hyperechoic  nodule, although  
relatively  uncommon,  is  more  likely to  be benign.  
 
Fig 27.round, hyperechoic homogeneous mass (arrow with peripheral 
halo )in patient with Hashimoto’s  thyroiditis.  
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The  isoechoic  nodule,  visible  because  of  a peripheral  
sonolucent  rim  that  separates  it  from  the  adjacent  normal  
parenchyma,  has  an  intermediate  to  low  risk of  malignancy.  
Isoechogenicity  has  low  sensitivity  but high  specificity  and  positive  
predictive  value  for  the  diagnosis  of  benign  nodules.  
Histologically,  it  is  thought  to  represent  the capsule  of  the  
nodule,  but  hyperplastic  nodules  that  have no  capsule  often  have  
this  sonographic  feature.  The hypothesis  that  it  represents  
compressed  normal  thyroid parenchyma  seems  acceptable,  especially  
for  rapidly growing  thyroid  cancers,  which  often  have  thick,  
irregular,  and  incomplete  halos    that  are hypovascular  or  avascular  
on  color  Doppler  scans.  
Color and  power  Doppler  imaging  demonstrates  that  the  
thin, complete  peripheral  halo,  which  is  strongly  suggestive  of 
benign  nodules,  represents  blood  vessels  coursing  around the  
periphery  of  the  lesion,  the  “basket  pattern.”  
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Fig 28 .Isoechoic nodule with surrounding thin rim of halo( arrows) 
 MARGIN: 
Benign  thyroid  nodules  tend  to  have  sharp, well -defined  
margins,  whereas  malignant  lesions  tend  to have  irregular,  
spiculated,  or  poorly  defined  margins.  For any  given  nodule,  
however,  the  appearance  of  the  outer margin  cannot  reliably  
predict  the  histologic  features because  many  exceptions  to  these  
general  trends  have been  identified,  even  if  the  association  of  
spiculated margins  with  malignant  nodules  has  recently  been  
demonstrated  as  highly  specific. 
CALCIFICATION:   
Calcification  can  be  detected  in  about 10%  to  15%  of  all  
thyroid  nodules,  but  the  location  and pattern  of  the  calcification  
have  a  more  predictive  value in  distinguishing  benign  from  
malignant  lesions.Peripheral  shell  (eggshell)  calcification,  although 
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rarely  present,  has  traditionally  been  considered  a  characteristic  of  
a  benign  nodule  . Thickened  and  interrupted  peripheral  
calcifications,  particularly  if  associated  with hypoechoic  halo,  have  
very  high  sensitivity  for  the  diagnosis  of  malignant  nature. 
Scattered  echogenic  foci of  calcification  with  or  without  associated  
acoustic shadows  are  more  common.  When  these  calcifications are  
large  and  coarse  (usually  related  to  fibrosis  and degeneration),  the  
nodule  is  more  likely  to  be  a  benign nodule,  with  long  disease  
duration.  When  the  calcifications  are  fine  and  punctate,  however,  
malignancy  is more  likely.  Pathologically,   these  fine  calcifications  
may be  caused  by  psammoma  bodies,  typically  seen  in  papillary  
cancers . Medullary thyroid  carcinomas  often  exhibit  bright echogenic  
foci  either  within  the  primary  tumor  or  within metastatically  
involved  cervical  lymph  nodes.The larger  echogenic  foci  are  
usually  associated  with  acousticshadowing.  Pathologically,  these  
densities  are  caused  by  reactive  fibrosis  and  calcification around  
amyloid  deposits,  which  are  characteristic  of medullary  carcinoma.  
In  the  appropriate  clinical  setting (e.g.,  MEN  II  syndrome,  
increased  serum  calcitonin level),  the  finding  of  echogenic  foci  
within  a  hypoechoic thyroid  nodule  or  a  cervical  node  can  be  
highly  suggestive  of  medullary  carcinoma. There is a strong  
association  between sonographically  detected  thyroid  calcifications  
and thyroid  malignancy,  particularly  in  young  patients  or those  with  
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a  solitary  thyroid  nodule.  The  presence  of  calcifications  within  a  
solitary  nodule  increases  the  incidence  of  malignancy.   Various  
sonographic  features  seen  in  thyroid  nodules,  microcalcifications  
show  the  highest  accuracy  (76%),  specificity (93%),  and  positive  
predictive  value  (70%)  for  malignancy  as  a  single  sign.  However,  
sensitivity  is  low  (36%)  and  insufficient  to  be  reliable  for  
detection  of malignancy. 
DOPPLER  FLOW  PATTERN.     
Most  hyperplastic  nodules  are  hypovascular  lesions  and  are  
less  vascular  than  normal  thyroid parenchyma. 
On  the  contrary,  most  well-differentiated thyroid  carcinomas  
are  generally  hypervascular,  with irregular  tortuous  vessels  and  AV  
shunting  . 
Poorly  differentiated  and  anaplastic  carcinomas  are  often 
hypovascular  because  of  the  extensive necrosis  associated  with  
their  rapid  growth. 
Quantitative  analysis  of  flow  velocities  is  not  accurate in  
differentiating  benign  from  malignant  nodules,  so  the only  Doppler  
feature  that  may  be  useful  is  the  distribution  of  vessels.  
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The  two  main categories  of  vessel  distribution  are  nodules  
with  peripheral  vascularity  and  nodules  with  internal  vascularity 
(with  or  without  a  peripheral  component).  
80%  to  95%  of  hyperplastic, goitrous,  and  adenomatous  
nodules  display  peripheral vascularity.  
70%  to  90%  of  thyroid  malignancies  display  internal  
vascularity,  with  or  without  a peripheral  component.  
Gray-scale  and  color  Doppler  ultrasound  findings become  
highly  predictive  for  malignancy  only when  multiple  signs  are  
simultaneously  present  in  a nodule.  
The  combination  of  absent  halo sign  plus  microcalcifications  
plus  intranodular  flow pattern  achieved  a  97.2%  specificity  for  the  
diagnosis of  thyroid  malignancy. 
In  a  recent  report  the  presence of  at  least  one  malignant  
sonographic  finding  (tallerthan-wide  shape,  spiculated  margin,  
marked  hypoechogenicity,  microcalcification  and  macrocalcification)  
had sensitivity  of  83.3%,  specificity  of  74.0%,  and  diagnostic  
accuracy  of  78.0%. 
The  presence  of  other  findings (e.g.,  rim  calcification)  
showed  no  statistical  significance in  the  differentiation  of  a  
malignant  nodule  from  a benign  nodule. 
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Following table shows reliability of sonographic features in 
differentiation of benign from malignant thyroid nodules . 
 
FNAC : 
It  is   recognized  that  FNAC is  the  most effective  method  for  
diagnosing  malignancy  in  a  thyroid nodule.  FNAC  has  had  a  
substantial  impact  on  the  management  of  thyroid nodules  because  
it  provides  more  direct  information than  any  other  available  
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diagnostic  technique.  It  is  safe, inexpensive,  and  results  in  better  
selection  of  patients  for surgery. 
Fine-needle  thyroid  aspirates  are  often  classified  
cytopathologically  into  the  following  four  categories:  
1) Negative  (no  malignant  cells) 
2) Positive  for  malignancy 
3) Suggestive  of  malignancy 
4) Nondiagnostic 
If  a  nodule  is  classified  in  either  of  the  first  two  
categories, the  results  are  highly  sensitive  and  specific.The  major 
limitation  of  the  technique  is  the  lack  of  specificity  in  the third  
group,  whose  results  are  suggestive  of  malignancy. In  these  cases,  
surgical  excision  is  required  for diagnosis.  In  addition,  up  to  20%  
of  aspirates  may  be nondiagnostic,  approximately  half  of  which  
result  from inadequate  cell  sampling  of  cystic  lesions.  
In  these  cases, repeat  FNAC  under  sonographic  guidance  can  
be  performed  for  selective  sampling  of  the  solid  elements  of the  
mass.  In  the  literature,  FNAC  of  thyroid  nodules has  a  sensitivity  
range  of  65%  to  98%  and  specificity  of 72%  to  100%.   
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THYROID    SONOELASTOGRAPHY : 
A new sonographic technique called sonoelastography (or 
elastosonography) has been applied to the  study of thyroid nodules, 
following the results achieved  for breast nodules. 
Sonoelastography provides information   on tissue elasticity, based 
on the  pathologic processes such as cancer alter the physical  
characteristics of the involved tissue.  
Sonoelastographic  measurements are performed during the 
ultrasound  examination, using the same ultrasound machine and  the 
same transducer .  The ultrasound elastogram is displayed over the 
typical B-mode gray-scale ultrasound scan in a color scale  and 
classified by using the elasticity score
33,34.
 .To minimize interobserver 
and intraobserver variability, the freehand compression applied on the 
neck region is standardized  by real-time measurement displayed  to 
maintain an intermediate level optimal for elastographic   evaluation. 
USE is used  to assess the biomechanical properties of tissue in the 
clinical setting. Among different types of USE, strain USE was the first 
to be introduced into commercially available systems. It is based upon 
the principle that, under compression, the softer parts of tissues deform 
easier than the harder parts 
47
. The concept of USE was firstly conceived 
and realized in 1991 by Ophir et al
46
.  and gradually developed into a 
robust US examination method. It has recently gained great interest and 
attention and has found rapid diffusion in various diagnostic 
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applications, including the thyroid nodules 
48
. As shown by a number of 
studies, USE of thyroid nodules seems promising in differentiating 
benign from malignant nodules 
49,50,51
. The American Thyroid 
Association guidelines in 2009 stated that USE is an emerging and 
promising technique that requires additional validation with prospective 
studies . 
PHYSICAL PRINCIPLES AND TECHNIQUE OF STRAIN 
 USE : 
A deformation force is applied to tissue resulting in changes in 
dimensions and shape, which are then used to calculate the stiffness of 
the tissue. This is the underlying physical mechanism on which all forms 
of current commercially available USE methods are based. However, the 
alternative technologies differ according to the method used to deform 
tissue and the way they display deformation, leading to 3 main types of 
USE: strain USE, acoustic radiation force impulse (ARFI), and shear 
wave USE. 
Strain USE detects the local deformation (strain) under slight 
pressure and displays it as a relative value in comparison to the strain 
values of the different tissues within the region of interest. Strain USE is 
also named real-time ultrasound elastography (RTE), or strain 
elastography (SE), or free-hand elastography and is the most widely 
available type of USE. The pressure is performed either by the hand 
held US transducer or by physiological movements (e.g., carotid 
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pulsation). This results in the elastographic image, also known as 
elastogram, which is represented as a color coded image superimposed 
on the B-mode image and displayed next to it on the screen. The quality 
of the operator’s free-hand pressure is visualized on the screen as a sine-
wave , allowing the operator to assess the validity of the compression 
cycles in real-time. For computing strain images without noise, the light 
and cyclic probe pressure has to be harmonic with a near constant rate of 
displacement . In general, a rectangular, or elliptic, or rounded region of 
interest (ROI) is used, large enough to include the entire nodule as well 
as a large portion of the surrounding thyroid and perithyroid tissue. This 
technique allows a qualitative and a semiquantitative assessment of 
nodule elasticity. The qualitative assessment (elastogram) represents a 
mapping of the amount of tissue strain at each location . Color coding 
depends on the system and usually blue represents hard, stiff tissue 
(with lowest elastic strain or no strain), red represents soft tissue (with 
greatest elastic strain), and green or orange represents intermediate level 
of stiffness. 
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Fig 29.Benign thyroid nodule that appeared soft at SE, with score 2.  
 
Fig 30.Malignant thyroid nodule that appeared hard at SE,  
with score 4. 
QUALITATIVE USE SCORING SYSTEMS OF THYROID 
NODULES: 
Strain elastograms of nodules are qualitatively evaluated with a 
stepwise scoring system, according to the prevalent color in the nodule. 
The two principal scoring systems are those classified by Asteria et 
al.
52
and Rago et al.
53
. The first one, based on the breast strain USE scale 
of Itoh et al.
54
, includes four different patterns 
53
. The thyroid nodules 
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with scores 1 and 2 are considered benign (Figure 1) and those with 
scores 3 and 4 are classified as suspicious for malignancy
52
. 
A modified Asteria scale was used by Rubaltelli et al. both for 
thyroid nodules 
60
 and neck lymph nodes 
61
. It consists of a five-step 
system that divides Asteria score 3 into patterns 3A and 3B, with a scale 
description as follows. 
Pattern 1: the entire nodule section is diffusely elastic.  
Pattern 2: the formation appears to be largely elastic with the 
inconstant appearance of anelastic     areas during the real -time 
examination. 
Pattern 3: constant presence of large anelastic areas is seen at the 
periphery 
(Pattern 3A) or  center (Pattern 3B) of the formation. 
Pattern 4: uniformly displayed anelasticity throughout the whole 
nodule. 
Lesions that present Pattern 1 or 2 are classified as probably 
benign, while Patterns 3 and 4 are indicative of probable 
malignancy
60,61
. 
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  DIAGNOSTIC PERFORMANCE OF USE : 
For the differentiation of malignant and benign thyroid nodules, a 
number of literature reports show encouraging results for SE. The 
diagnostic performances of the main studies are presented in Table  1. 
Diagnostic performance in malignancy detection, of SE with color 
coded scale for elasticity evaluation, in selected studied. 
Study 
Number 
of 
nodules 
Sensitivity 
% 
Specificity 
% 
Reference 
standard 
Rago et al., 
2007 [29] 
92 97 100 Surgery 
Asteria et al., 
2008 [28] 
86 94 81 FNAB or  
surgery 
Tranquart et 
al., 2008 [60] 
108 100 93 FNAB 
Hong et al., 
2009 [23] 
145 88 90 Surgery 
Rubaltelli et 
al., 2009 [32] 
51 82 86 FNAB or  
surgery 
Lippolis et al., 
2011 [49] 
102 89 6 Presurgery of 
indeterminate 
cytology 
(follicular) 
Moon et al., 
2012 [44] 
703 65 58 FNAB or  
surgery 
Azizi et al., 
2013 [31] 
912 80 70 FNAB or  
surgery 
Ko et al., 2014 
[61] 
367 89 81 FNAB or  
surgery 
Mehrotra et 
al., 2013 [62] 
146 90 79 FNAB or  
surgery 
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FUTURE PROSPECTS 
 
SE is expected to technically evolve in the upcoming  years. 
Volumetric 3D elasticity images with 3D probes are currently being 
developed and  resulting in high-resolution 3D strain-volumetric images 
. Initial data in thyroid , breast and testis show that in vivo 3D strain 
imaging is feasible and may have the potential to reduce noise and helps 
to differentiate cystic and solid lesions . More work has  to be done  on 
standardization of the technique. Dedicated thyroid USE protocols are 
expected to develop in  future   to overcome the limitations. 
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AIMS AND OBJECTIVES  
AIM 
To compare sonography combined with  USE findings of thyroid 
lesion with the cytological results of fine-needle aspiration cytology and 
determine the accuracy of ultrasound  combined  USE  findings in the 
diagnosis of thyroid lesions. 
OBJECTIVE 
Ultrasonographic  and USE evaluation of  thyroid  lesions  as 
benign ,intermediate or malignant. To compare  the accuracy of 
Ultrasonographic findings   with  fine needle aspiration cytology 
(FNAC) in the diagnosis, sensitivity, specificity ,PPV,NPV and overall 
accuracy.. 
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MATERIALS AND METHODS 
This is a prospective study  with 100 patients. A written 
“informed consent” was taken from patients before performing 
Ultrasound , USE and US- FNAC. Ultrasound guided fine needle 
aspiration cytology will be collected from patients presented for a 
thyroid  lesion after detailed sonographic evaluation. 
EVALUATION OF PATIENTS 
Detailed sonographic evaluation of thyroid lesion noted under the  
following headings 
 Location 
 Internal content  -solid, cystic, mixed 
 Homogenous or heterogenous Parenchymal interface 
 Echogenicity 
 Posterior Sound TransmissionEnhancement, shadow, no change  
 Lateral edge shadowing present or absent.  
 Cystic lesions with septations. 
Result of the examination will be interpreted on basis of these 
findings and diagnosis will be proposed after considering history and 
physical examination. 
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METHOD OF US- FNAC  
FNAC will be performed by using 10 ml disposable syringe with  
24-gauge needle by using a perpendicular puncture and without local 
anesthesia.  After a sample was obtained, the specimen was mounted 
immediately onto a glass slide. Specimens are fixed with 95% ethanol 
and will be sent for pathological evaluation.  
SUBJECT SELECTION` 
Inclusion Criteria 
1) Physical examination suggestive of palpable thyroid swelling in 
lower neck in midline or oneither side.  
2) Signs and symptoms suggestive of thyroid Disorder(hypo or 
hyperthyroidism) 
Exclusion Criteria 
1) Patient not  willing for study 
2) Patient already diagnosed and treated for thyroid disorder  
3) Pregnancy 
4) FNAC showing inadequate aspirated material  
ASSESSMENTS OF PARAMETERS: 
 Ultrasound Findings 
 Echogenecity 
 Margin 
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 Calcifications 
 Shape 
 Consistency -Cystic, solid or mixed 
 Impression 
 Benign 
 Intermediate 
 Malignant 
 USE 
 Benign 
 Malgnant 
 FNAC 
 Benign  
 Suspicious for malignancy 
 Malignant 
 Interpretation 
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 REPRESENTATIVE  CASES 
 CASE .1 
 
Fig .31.1 showing   benign , welldefined , oval , hyperechoic nodule 
with  thin  surrounding halo.  
 
 
Figure 31.2  shows predominantly  firm  elastographic appearance of 
the same nodule    Which was HPE proven  hyperplastic nodule         
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CASE .2 
 
Fig  31.3 shows welldefined , oval ,heteroechoic nodule with thin 
surrounding    Halo. 
 
 
Fig  31.4 shows predominantly hard  elastographic appearance of the 
same Nodule.    FNAC  shows papillary carcinoma. 
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CASE .3 
 
Fig 31.5 shows cystic nodule in grayscale USG. 
 
 
Fig 31.6 shows hard elastographic appearance of  cystic portion with 
firm nodule. 
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CASE .4 
 
Fig 31.7 shows  benign nodule with cystic change 
 
 
Fig 31.8  shows predominantly firm nodule in elastography with hard 
cystic area. FNAC  revealed nodular colloid goiter  
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CASE .5 
   
Fig 31.9 shows  benign nodule with spongiform appearance.  
 
 
Fig 31.10 shows firm elastographic appearance  of the same nodule. 
FNAC  showed colloid goiter. 
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STATISTICAL  ANALYSIS 
Total number of patients studied   is 100.  
Number of female patients :  94. 
Number of male patient: 6. 
Age of the patient ranges from  14 to 70years .  
100  patients  with  neck swelling  who came for  thyroid usg   
included in this study.  Thyroid   ultrasound  , Colour  Doppler ,  thyroid  
sonoelastography  was done  for all patients.  
Usg guided  FNAC   was done  from  100  nodules  ( suspicious 
nodules  in case on multinodular goiter ).  The histopathological  reports  
were  collected and correlated  with  usg  gray scale findings 
,elastographic finding and  combined  gray scale with elastographic 
findings 
The collected data were analysed with IBM.SPSS statistics 
software 23.0 Version. To describe about the data descriptive statistics 
frequency analysis, percentage analysis were used for categorical 
variables and the mean & S.D were used for continuous variables. To 
find the efficacy of the tools with Sensitivity, Specificity, PPV and NPV 
was used. 
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Table 1 . Gender distribution of the patients in this study     
SEX 
 Frequency Percent 
Female 94 94.0 
Male 6 6.0 
Total 100 100.0 
 
 
Fig. 32. Pie chart representation of  gender distribution 
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Table 2.  Frequency distribution of lesion detected by  FNAC 
 FREQUENCY PERCENT 
BENIGN   3 3 
MALIGNANT 97 97 
 
0 50 100 150
MALIGN
ANT
BENIGN
 
Fig . 33 . Bar chart  representation of  FNAC  diagnosis  Out of 100 
patients , FNAC revealed  3 malignant  nodules.  
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 Table  3.Frequency and charecterisation of lesion by  gray scale 
findings 
 FREQUENCY PERCENT 
BENIGN 89 89 
INDETERMINATE 9 9 
MALIGNANT 2 2 
TOTAL 100 100 
 
BENIGN
INDERMEDIATE
MALIGNANT
 
Fig .34.Frequency distribution of lesion by usg gray scale findings  
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Table 4 : Comparision of  gray scale findings  and FNAC 
  
FNAC 
Total 
Malignant Benign 
Gray Scale Findings Malignant 3 8 11 
Benign 0 89 89 
Total 3 97 100 
Tab . 5. Diagnostic performance of  gray scale usg  in detecting 
malignant thyroid nodule 
Sensitivity Specificity PPV NPV Overall  Accuracy 
100 91.8 27.3 100 95.9 
Table.6.  Frequency and charecterisation  of lesion by  elastography 
 Frequency Percent 
BENIGN 88 88 
MALIGNANT 12 12 
Fig .35.  Pie chart of charecterisation  of lesion by  elastography  
BENIGN
MALIGNAN
T
ELASTOGRAPHY
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  Table 7.  Frequency and charecterisation of  elastographic findings  
 Frequency Percent 
Soft 12 12 
Firm 76 76 
Hard 12 12 
Total 100 100 
 
  Fig .36.Frequency and charecterisation of  elastographic findings  
FIRM
SOFT
HARD
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Table 8 : Comparision of  elastographic  findings  and FNAC 
  
FNAC 
Total 
Malignant Benign 
Elastography Malignant 3 10 13 
Benign 0 87 87 
Total 3 97 100 
      Tab . 9. Diagnostic  performance of  elastography in detecting 
malignant thyroid nodule 
Sensitivity Specificity PPV NPV Overall  Accuracy 
100 89.7 23.1 100 94.85 
Table .10. Frequency and  charecterisation of lesion  by  usg –
grayscale  findings with   elastography 
 FREQUENCY PERCENT 
BENIGN 96 96 
MALIGNANT 4 4 
Fig .37. Pie chart representing  charecterisation of lesion  by  usg –
grayscale findings with   elastography 
BENIGN
96%
MALIGNANT
4%
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Table-11 : Comparision of USG gray scale with   elastographic  
findings  and FNAC 
  
FNAC 
Total 
Malignant Benign 
USG with elastography Malignant 3 1 4 
Benign 0 96 96 
Total 3 97 100 
Tab . 12. Diagnostic  performance of  USG grayscale imaging with 
elastography in detecting malignant  thyroid nodule.  
Sensitivity Specificity PPV NPV Overall  Accuracy 
100 99 75 100 99.5 
CROSSTABULATION  OF GRAY SCALE FINDINGS * FNAC 
Count  
FNAC 
Malignant Benign Total 
Gray scale findings Malignant 3 8 11 
Benign 0 89 89 
Total  3 97 100 
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CHI-SQUARE TESTS 
 Value df 
Asymp. 
Sig. (2-
sided) 
Exact 
Sig. (2- 
sided) 
Exact 
Sig. (1- 
sided) 
Pearson Chi-Square 25.023a 1 .000   
Continuity 
Correctionb 
16.529 1 .000   
Likelihood Ratio 14.057 1 .000   
Fisher's Exact Test 
Linear-by-Linear 
Association 
24.773 1 .000 .001 .001 
No. of Valid Cases 100     
 
a. 2 cells (50.0%) have expected count less than 5. The minimum 
expected count is .33.  
b a. 2 cells (50.0%) have expected count less than 5. The 
minimum expected count is .33. 
SYMMETRIC MEASURES  
 
 
Asymp. Std. Approx. 
Tb 
Approx. 
Sig. Value Errora 
Measure of Agreement   
Kappa 
.400 .163 5.002 .000 
N of Valid Cases 100    
a. Not assuming the null hypothesis.  
b. Using the asymptotic standard error assuming the null 
hypothesis. 
b. Computed only for a 2x2 
Computed only for a 2x2 table 
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CROSS TABULATION OF  ELASTOGRAPHY * FNAC 
COUNT 
 
 FNAC  
 Malignant Benign Total 
Elastography   Malignant 3 10 13 
Benign 0 87 87 
Total 3 97 100 
CHI-SQUARE TESTS 
 
 Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2- sided) 
Exact Sig. 
(1- sided) 
Pearson Chi-
Square 
20.698a 1 .000   
Continuity 
Correctionb 
13.527 1 .000   
Likelihood Ratio 12.903 1 .000   
Fisher's Exact 
Test 
   .002 .002 
Linear-by-Linear 
Association 
20.491 1 .000   
N of Valid Cases 100     
a. 2 cells (50.0%) have expected count less than 5. The minimum 
expected count is .39. 
b. Computed only for a 2x2 table  
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SYMMETRIC MEASURES 
  Value 
Asymp. Std. 
Errora 
Approx. 
Tb 
Approx. 
Sig. 
Measure of 
Agreement 
Kappa .343 .149 4.549 .000 
N of Valid 
Cases 
 100    
a. Not assuming the null hypothesis. 
b. Using the asymptotic standard error assuming the null 
hypothesis. 
CROSSTABULATION OF USG WITH ELASTOGRAPHY * 
FNAC 
CROSSTAB 
Count FNAC Malignant Benign Total 
USG With Elastography Malignant 3 1 4 
Benign 0 96 96 
Total  3 97 100 
CHI-SQUARE TESTS 
 Value df 
Asymp. 
Sig. (2-
sided) 
Exact 
Sig. (2- 
sided) 
Exact 
Sig. (1- 
sided) 
Pearson Chi-Square 74.227a 1 .000   
Continuity 
Correctionb 
50.691 1 .000   
Likelihood Ratio 22.450 1 .000   
Fisher's Exact Test 
Linear-by-Linear 
Association 
73.485 1 .000  .000 
N of Valid Cases 100     
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a. 3 cells (75.0%) have expected count less than 5. The minimum 
expected count is .12. 
b. Computed only for a 2x2 table 
SYMMETRIC MEASURES 
  Value 
Asymp.  
Std. 
Errora 
Approx. 
Tb 
Approx. 
Sig. 
Measure of 
Agreement 
Kappa .852 .146 8.615 .000 
N of Valid Cases  100    
 
a. Not assuming the null hypothesis.  
b. Using the asymptotic standard error assuming the null 
hypothesis 
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Case Processing FNAC Summary (Listwise) Valid N 
Positive 3  
Negative 97  
Smaller values of the test   result variable(s) indicate   stronger 
evidence for a positive actual state.  The positive actual state is  
Malignant.  
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AREA UNDER THE CURVE 
Test Result 
Variable(s) 
Area 
Std. 
Errora 
Asymptotic Sig.b 
Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Gray scale 
findings 
.959 .022 .007 .915 1.000 
Elastography .948 .026 .008 .897 .999 
USG with 
elastography 
.995 .007 .004 .982 1.000 
The test result variable(s): GRAY SCALE FINDINGS, 
ELASTOGRAPHY, USG WITH ELASTOGRAPHY has at least one tie 
between the positive actual state group and the negative actual state 
group. Statistics may be biased. 
a. Under the nonparametric assumption 
b. Null hypothesis: true area = 0.5 
Tab.12.Consolidated table of statistical  variables for Gray scale 
findings , Elastography and Both. 
Diagnostic  
tools 
AUC 
Sensi  
-tivity 
Speci 
-ficity 
PPV NPV 
Overall 
accuracy 
Kappa 
Kappa      
P-value 
Gray Scale .959 100 91.8 27.3 100 95.90 0.40 0.0005** 
Elastography .948 100 89.7 23.1 100 94.84 0.34 0.0005** 
USG with 
Elastography 
.995 100 99.0 75.0 100 99.50 0.85 0.0005** 
** Highly Sig. at P< 0.01 level 
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RESULTS 
 DEMOGRAPHIC CHARACTERISTICS 
Table.1& Figure.32  showed the gender frequency of the study. 
Out of  100 patients 94 were females and 6 were males.Most common 
presenting symptom is neck swelling. Age of the patients was not 
associated with malignancy.  
GRAY SCALE FINDINGS ASSOCIATED WITH BENIGN 
AND MALIGNANT NODULES 
Table .3 and figure 34 showed frequency  distribution and 
characterization of benign and malignant lesions by USG gray scale 
findings. Benign lesions are well defined, hyperechoic or isoechoic 
,wider than tall, purely cystic or cyst with thin septa and surounding thin 
halo. Malignant lesions are taller than wide ,irregular, illdefined, 
hypoechic ,solid lesions with microcalcifications.  
DIAGNOSTIC PERFORMANCE OF    GRAY SCALE USG  
Table 2 and figure 33 explained about FNAC results.  
3 lesions were malignant and rest of the nodules were benign.  
Gray scale findings differentiate 89 benign nodules  and 2 
malignant nodules. 9 cases were indermediate  on grayscale USG. 
In this study, sensitivity of grayscale USG in detecting malignant 
thyroid nodules was 100%  but specifity was 91.8% . some  lesions were 
 
79 
overlooked compared with FNAC.   Table 5 showed the sensitivity and 
specificity of  grayscale USG. 
DIAGNOSTIC PERFORMANCE OF USE 
Table .6 and figure 35 showed frequency and characterisation of 
thyroid nodules by Elastography. 88 nodules were benign and 12 were 
probably malignant  on elastography.  In this 88 benign nodules ,12 
nodules were soft, 76 nodules were firm on elastography. 
Table 9 revealed the diagnostic performance of elastography. It 
showed sensitivity of   100% but specifity was 89.7 % . Here also some  
lesions were overlooked compared with FNAC.  Accuracy of gray-scale  
US features was mostly higher than that of elastography, but  it was not 
statistically significant . 
DIAGNOSTIC PERFORMANCE OF USG  COMBINED  WITH 
USE  
Table 10 and figure 37 revealed frequency and charecterisation  of 
the lesion by both gray scale and elastography. 96 benign nodules and 4 
probably malignant nodules were detected by using both techniques.  
Table 12 revealed the diagnostic performance of  combinig  usg 
gray scale  and  elastography.. It showed sensitivity of   100% but 
specifity was 99% .Overall  accuracy was 99.5%. 
According to  Moon WJ, Jung SL, Lee JH, et al.  reports, for the 
differentiation of  benign versus malignant thyroid nodules, sonography   
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has sensitivity rates of 63% to 94%, specificity of 61% to 95%, and 
overall accuracy of 78% to 94%. 
In   another study by Trimboli et al. [47], based on a prospective   
evaluation of 498 thyroid nodules, the combination of US  features with 
the SE four-class color scale yielded improvement   with 97% sensitivity 
and 97% NPV whereas US alone had 85% sensitivity and 91% negative 
predictive value. The  authors suggest that, by adding SE evaluation, the 
sensitivity  for malignancy of US findings is markedly increased and the  
selection of nodules that do not need cytology is made more reliable. US 
and SE  combined evaluation improves the diagnostic performance for 
thyroid cancer detection. 
In this study , out of 3 cases of carcinoma  detected by fnac , all 
are  detected by combining US AND USE   .In this evaluation of 100 
thyroid nodules , the combination of  US  features with the USE  yielded 
improvement  with  99% specificity  and 99.5% overall accuracy , 
whereas us alone had 91.8% specificity and 95.9 % overall accuracy 
with a highly  significant   p value( p < 0.01).  
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DISCUSSION 
This study was conducted to investigate the incremental  detection 
rate of malignant thyroid nodule by   grayscale USG in combination 
with USE. 
Elastography has been introduced to  evaluate hardness 
objectively, to improve the diagnostic performance of  gray-scale US 
examination in differential  diagnosis of thyroid nodules, and to  
eventually reduce unnecessary benign biopsies in thyroid nodule  .Many 
previous studies have proved that elastography is useful in 
differentiating  malignant from benign nodules. In our study,  our 
findings were consistent with those other studies.  
Elastography is usually performed in thyroid nodules detected at 
grayscale  US, and the high diagnostic performances of combinations of 
suspicious gray-scale US features are validated through many previous 
studies  as well as in our study. 
Accordingly, for elastography to be  used widely as an adjunctive 
diagnostic tool supporting gray-scale US or to be used as a separate 
diagnostic tool, several  conditions should be fulfilled. The  diagnostic 
performance of elastography itself or a combination of elastography and 
gray-scale US should be superior to that of gray-scale US alone. 
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 LIMITATIONS 
The limitations of SE are a result of technical issues associated 
with the application and physics of the technique aswell as the  
histological features of the nodules, leading to misinterpretations and 
pitfalls. 
SE in all its forms remains an examiner-dependent method. 
Nonuniform compressions produce intra- and interobserver variability . 
Therefore, several compression relaxation cycles are needed to ensure 
that quality data are  obtained 
Another important issue is  that prestress compression can result 
in misleadingly  high stiffness results,especially in superficial tissues 
like the thyroid. 
Another technical limitation is   the lack of standardization both 
in the technique application, the type of measurements obtained, the cut -
off values, and the color coding.  The existence of carotid artery 
pulsations generates variable tissue deformations leading to potential 
pitfalls in the SE evaluation . 
Besides inherent technical limitations, the histological  features of 
the nodules themselves may lead to pitfalls. Fibrosis  within a nodule 
can be a confounding factor in elasticity  imaging. There is no study 
evaluating fibrosis in thyroid nodules using SE; however, many studies 
on liver SE have proved a correlation between levels of stiffness and 
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fibrosis. Fibrosis may be a feature in both benign and malignant  
nodules and could therefore be a misleading factor. The  presence of 
autoimmune thyroiditis seems not to influence  the SE results , whereas 
calcifications, partially cystic or colloid components, isthmus location, 
nodule size, and the presence of multinodular goiter are correlated to 
increased levels of stiffness ..  
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CONCLUSION  
According to this study , it can be concluded that gray scale  USG  
in combination with elastography is an cost effective  , non – invasive 
and feasible  technique to detect  malignant thyroid nodule  with a high  
specificity. The study found that  US Elastography  is  a useful 
complement to  gray scale  US, enhancing its accuracy in detecting  
malignant thyroid nodules. 
Given the high prevalence of thyroid nodules and the substantial 
costs related to their workup and management,  gray scale  USG  in 
combination with elastography  could be a valuable tool for a better 
selection of  nodules that need  invasive procedures and it  can help in 
identifying patients in need of  FNAC or Biopsy  .  
Gray scale  USG  in combination with elastography may also  be 
used to guide the follow-up of  suspicious  lesions negative for 
malignancy  at  FNAC. 
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INFORMED CONSENT FORM 
TITLE : “ STRAIN USG ELASTOGRAPHY WITH GRAY 
SCALE AND  COLOUR  DOPPLER  IMAGING OF 
THYROID NODULES –  EFFICACY COMPARED 
WITH FNAC ” 
Study Centre: Barnard Institute of Radiology, 
Madras Medical College & 
Rajiv Gandhi Govt. General Hospital,  
Chennai – 600003. 
Participant  : 
Name :    Age :   Sex : 
I confirm that I have understood the purpose of procedure for the 
above study. I have the opportunity to ask the questions and all my 
questions and doubts have been answered to my satisfaction. 
I have been explained about the pitfall in the procedure. I have 
been explained about the safety, advantage and disadvantage of the 
technique. I understand that my participation in the study is voluntary 
and that I am free to withdraw at anytime without giving any reason.  
I understand that investigator, regulatory authorities and the ethics 
committee will not need my permission to look at my health records 
both in respect to current study and any further research that may be 
conducted in relation to it, even if I withdraw from the study. I 
understand that my identity will not be revealed in any information 
released to third parties or published, unless as required under the law. I 
agree not to restrict the use of any data or results that arise from the 
study. 
I have been explained that the USG CHARACTERISATION OF 
THYROID LESIONS is a standard and approved technique. This may 
help in future research in the field of radiology. I consent to undergo 
this procedure. 
 
Date :   Signature / Thumb Impression of Patient. 
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PATIENT INFORMATION SHEET 
TITLE: “ STRAIN USG ELASTOGRAPHY WITH GRAY 
SCALE AND  COLOUR  DOPPLER  IMAGING OF 
THYROID NODULES –  EFFICACY COMPARED 
WITH FNAC ” 
 We are conducting a study on thyroid lesions among patients 
attending Government General Hospital, Chennai and for that 
your specimen may be valuable to us.  
 The purpose of this study is to diagnose cases of thyroid lesions 
easily with the help of certain special tests.  
 The privacy of the patients in the research will be maintained 
throughout the study. In the event of any publication or 
presentation resulting from the research, no personally 
identifiable information will be shared.  
 Taking part in this study is voluntary. You are free to decide 
whether to participate in this study or to withdraw at any time; 
your decision will not result in any loss of benefits to which you 
are otherwise entitled.  
 The results of the special study may be intimated to you at the end 
of the study period or during the study if anything is found 
abnormal which may aid in the management or treatment.  
 
 
Signature of investigator Signature of participant 
(Dr. A. Karpagavalli) 
Date : 
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PROFORMA 
Study Title:  STRAIN USG ELASTOGRAPHY WITH GRAY 
SCALE AND  COLOUR  DOPPLER  IMAGING 
OF THYROID NODULES –  EFFICACY 
COMPARED WITH FNAC ” 
SL.No. 
Name  :       Age / Sex : 
Occupation  : 
Address : 
Presenting Complaints : 
Past History (if any) : 
Investigations (if any) : 
 Ultrasound Findings 
 Shape 
 Internal contents 
 Echogenecity 
 Halo 
 Margin 
 Calcifications 
 Colour Doppler 
 Peripheral flow pattern 
 Internal flow pattern   
 Sonoelastography 
 Soft 
 Firm 
 Hard 
 Impression 
 Benign 
 Suspicious 
 Malignant 
 FNAC 
 Benign  
 Indeterminate 
 Suspicious for malignancy 
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ABBREVIATIONS 
CT Computed Tomography 
MRI Magnetic resonance imaging. 
USG  Ultrasonogram 
USE  Uitrasound elastography 
FNAC  Fine Needle Aspiration Cytology 
HPE  Histo pathological examination 
FNAB Fine Needle Aspiration Biopsy 
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NAME OF THE PATIENT AGE SEX GRAY SCALE FINDINGS
COLOUR 
DOPPLER
COLOUR DOPPLER ELASTOGRAPHY ELASTOGRAPHY
USG WITH 
ELASTOGRAPHY
FNAC FNAC
KANNIYAMMAL 70 F BENIGN PERIPHERAL FLOW  PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
ALAMELU 50 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN
 COLOID GOITRE WITH CYSTIC 
DEGENARATION
BENIGN
LILLY 55 F INDERMEDIATE PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  SOFT BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
AMUDHA 36 F BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN THYROIDITIS BENIGN
VASU 14 M BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  SOFT BENIGN BENIGN THYROIDITIS BENIGN
SARITHA 27 F INDERMEDIATE PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN COLLOID GOITRE BENIGN
SAMPOORANAM 35 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN COLLOID GOITRE BENIGN
CHITRAKALA 47 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
MALARVIZHI 44 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  HARD MALIGNANT BENIGN
 COLOID GOITRE WITH CYSTIC 
DEGENARATION
BENIGN
KALA 27 F MALIGNANT PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  HARD MALIGNANT MALIGNANT PAPILLARY CARCINOMA MALIGNANT
MUNIYAMMAL 45 F BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
SAVITHA 41 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  SOFT BENIGN BENIGN ADENOMATOUS NODULE BENIGN
MUBINA 58 F INDERMEDIATE PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN
COLLOID GOITRE WITH 
THYROIDITIS
BENIGN
MURALIKRISHNA 26 M INDERMEDIATE PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  HARD MALIGNANT MALIGNANT PAPILLARY CARCINOMA MALIGNANT
VALLIYAMMAL 66 F INDERMEDIATE PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  HARD MALIGNANT BENIGN
ADENOMATOUS GOITRE WITH 
THYROIDITIS
BENIGN
SELVI 34 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
KARTHICK 30 M MALIGNANT PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  HARD MALIGNANT MALIGNANT FOLLICULAR NEOPLASM MALIGNANT
SARALA 42 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
BARATHI 35 M BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN THYROIDITIS BENIGN
MENAKA 38 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
SHAKILA 52 F INDERMEDIATE PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN ADENOMATOUS NODULE BENIGN
MANJULA 47 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN COLLOID GOITRE BENIGN
KANMANI 38 F BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
KUMARI 40 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
DHANALAKSHMI 45 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
ELLAMMAL 55 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN HYPERPLASTIC NODULE BENIGN
NAME OF THE PATIENT AGE SEX GRAY SCALE FINDINGS
COLOUR 
DOPPLER
COLOUR DOPPLER ELASTOGRAPHY ELASTOGRAPHY
USG WITH 
ELASTOGRAPHY
FNAC FNAC
JAYAMANI 35 F INDERMEDIATE PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
KASI 38 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  SOFT BENIGN BENIGN THYROIDITIS BENIGN
BACKIUM 40 F BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN ADENOMATOUS NODULE BENIGN
KANI 44 M BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
MALLIKA 50 F BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  SOFT BENIGN BENIGN THYROIDITIS BENIGN
YOGALAKSHMI 58 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
SUSILA 45 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  SOFT BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
VANI 42 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN LYMPHOCYTIC THYROIDITIS BENIGN
VARALAKSHMI 38 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  HARD MALIGNANT BENIGN
 COLOID GOITRE WITH CYSTIC 
DEGENARATION
BENIGN
SAKTHI 44 M BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
KAMALA 50 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
VASANTHA 31 F BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN LYMPHOCYTIC THYROIDITIS BENIGN
AMBIKA 52 F BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN HASHIMOTOS THYROIDITIS BENIGN
PRIYA 39 F BENIGN AVASCULAR PREDOMINANTLY  HARD MALIGNANT BENIGN
 COLOID GOITRE WITH CYSTIC 
DEGENARATION
BENIGN
YASMIN 42 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
HEMALATHA 51 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
SURYA 44 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
AKILA 43 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
JESINTHA 40 F BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN LYMPHOCYTIC THYROIDITIS BENIGN
SARANYA 49 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
ALLIYAMMAL 38 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
SUDHA 55 F BENIGN AVASCULAR PREDOMINANTLY  HARD MALIGNANT BENIGN
 COLOID GOITRE WITH CYSTIC 
DEGENARATION
BENIGN
THARA 42 F BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN LYMPHOCYTIC THYROIDITIS BENIGN
PRABA 53 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
NALINI 46 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN ADENOMATOUS NODULE BENIGN
FATHIMA 39 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
NAME OF THE PATIENT AGE SEX GRAY SCALE FINDINGS
COLOUR 
DOPPLER
COLOUR DOPPLER ELASTOGRAPHY ELASTOGRAPHY
USG WITH 
ELASTOGRAPHY
FNAC FNAC
NISHANTHI 42 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
RAMYA 55 F BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN HASHIMOTOS THYROIDITIS BENIGN
KANNAGI 52 F BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
DEEPA 48 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
SHAKIRA BANU 50 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN HYPERPLASTIC NODULE BENIGN
SHANMUGAVALLI 37 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
GAYATHRI 41 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
NIRMALA 48 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
KALPANA 56 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
ARCHANA 44 F BENIGN AVASCULAR PREDOMINANTLY  HARD MALIGNANT BENIGN
 COLOID GOITRE WITH CYSTIC 
DEGENARATION
BENIGN
LAKSHMI 63 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  SOFT BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
VINOTHINI 41 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
MARYAMMAL 59 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
VADIVU 38 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
VALLI 49 F BENIGN AVASCULAR PREDOMINANTLY  HARD MALIGNANT BENIGN
 COLOID GOITRE WITH CYSTIC 
DEGENARATION
BENIGN
MAHESWARI 53 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  SOFT BENIGN BENIGN ADENOMATOUS NODULE BENIGN
PUSPHA 47 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  SOFT BENIGN BENIGN NODULAR COLLOID GOITRE BENIGN
LATHA 40 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN COLLOID GOITRE BENIGN
ANDAL 54 F BENIGN AVASCULAR PREDOMINANTLY  HARD MALIGNANT BENIGN
 COLOID GOITRE WITH CYSTIC 
DEGENARATION
BENIGN
KRISHNAMMAL 61 F INDERMEDIATE PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN COLLOID GOITRE BENIGN
SIVAKOLUNDHU 58 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN COLLOID GOITRE BENIGN
THULASI 35 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN COLLOID GOITRE BENIGN
RADHA 38 F BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN HASHIMOTOS THYROIDITIS BENIGN
KALA 43 F BENIGN AVASCULAR PREDOMINANTLY  HARD MALIGNANT BENIGN
 COLOID GOITRE WITH CYSTIC 
DEGENARATION
BENIGN
PREMA 33 F BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN LYMPHOCYTIC THYROIDITIS BENIGN
DEVI 48 F BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  SOFT BENIGN BENIGN HYPERPLASTIC NODULE BENIGN
NAME OF THE PATIENT AGE SEX GRAY SCALE FINDINGS
COLOUR 
DOPPLER
COLOUR DOPPLER ELASTOGRAPHY ELASTOGRAPHY
USG WITH 
ELASTOGRAPHY
FNAC FNAC
POOCHENDU 47 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN COLLOID GOITRE BENIGN
JAYAMMAL 62 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN COLLOID GOITRE BENIGN
SRIDEVI 38 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN HYPERPLASTIC NODULE BENIGN
VASINI 41 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN HYPERPLASTIC NODULE BENIGN
SEKAR 45 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN COLLOID GOITRE BENIGN
AYISHA 42 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  SOFT BENIGN BENIGN COLLOID GOITRE BENIGN
KALAIVANI 52 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN COLLOID GOITRE BENIGN
CHELLAMMAL 55 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN LYMPHOCYTIC THYROIDITIS BENIGN
ARUNA 49 F BENIGN AVASCULAR PREDOMINANTLY  HARD MALIGNANT BENIGN
 COLOID GOITRE WITH CYSTIC 
DEGENARATION
BENIGN
NEELAVENI 46 F BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN HYPERPLASTIC NODULE BENIGN
LATHA 52 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN COLLOID GOITRE BENIGN
AARTHI 39 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN COLLOID GOITRE BENIGN
SARASU 57 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN HYPERPLASTIC NODULE BENIGN
SINDHU 34 F BENIGN PERIPHERAL AND CENTRAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN LYMPHOCYTIC THYROIDITIS BENIGN
JANAKI 61 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN HYPERPLASTIC NODULE BENIGN
KOTHAI NAYAKI 55 F INDERMEDIATE PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN  COLOID GOITRE BENIGN
RAJALAKSHMI 54 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN COLLOID GOITRE BENIGN
JULIET 39 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  SOFT BENIGN BENIGN COLLOID GOITRE BENIGN
MADHAVI 36 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN COLLOID GOITRE BENIGN
SUGANDHI 44 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN HYPERPLASTIC NODULE BENIGN
MANGAI 47 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN COLLOID GOITRE BENIGN
MALARKODI 52 F BENIGN PERIPHERAL FLOW PREDOMINANTLY  FIRM BENIGN BENIGN HYPERPLASTIC NODULE BENIGN
NONE OF THE PEAK SYSTOLIC  FLOW VELOCITIES  EXCEEDS 70 CM/SEC, VELOCITIES EXCEED 70 CM/S
Bµõ´a] uPÁÀuõÒ 
 
 
ö\ßøÚ Aµ_ ö£õx ©¸zxÁ©øÚUS Á¸® ÷{õ¯õÎPÎh® C¸US® 
øuµõ´kPmiPøÍ¨ £ØÔ¯ J¸ Bµõ´a] C[S {øhö£ØÖÁ¸QßÓx. 
 
øuµõ´kPmiPÎ÷»÷¯ £Ø£» ÁøPPÒ Esk. A¢uPmiPøÍ ]» ]Ó¨¦¨ 
£¶÷\õuøÚPÎß _»® GÎvÀPsk¤izxBµõ¯ ¬i²® Gß£÷u 
C¢uBµõ´a]°ß ÷{õUP©õS®. 
 
}[PÐ® C¢uBµõ´a]°À £[÷PØP {õ[PÒ Â¸®¦Q÷Óõ®. 
C¢uBµõ´a]°À E[PÐøh¯ v_UPøÍGkzx ]» ]Ó¨¦¨ 
£¶÷\õuøÚUSEm£kzvAußuPÁÀPøÍBµõ´÷Áõ®. AuÚõÀu[PÍx 
÷{õ°ßB´ÁÔUøP÷¯õ AÀ»x ]Qaø\÷¯õ £õv¨¦USÒÍõPõx Gß£øu²® 
öu¶ÂzxUöPõÒQ÷Óõ®. 
 
¬iÄPøÍAÀ»xP¸zxPøÍöÁÎ°k® ÷£õ÷uõAÀ»xBµõ´a]°ß 
÷£õ÷uõ u[PÍx ö£¯øµ÷¯õ AÀ»xAøh¯õÍ[PøÍ÷¯õ öÁÎ°h ©õm÷hõ® 
Gß£øu²® öu¶ÂzxUöPõÒQ÷Óõ®. 
 
C¢uBµõ´a]°À £[÷PØ£x u[PÐøh¯ Â¸¨£zvß ÷£¶À 
uõßC¸UQÓx. ÷©¾® }[PÒ G¢÷{µ¬® C¢uBµõ´a]°À C¸¢x ¤ßÁõ[P»õ® 
Gß£øu²® öu¶ÂzxUöPõÒQ÷Óõ®. 
 
 C¢u ]Ó¨¦¨ £¶÷\õuøÚPÎß ¬iÄPøÍBµõ´a]°ß 
÷£õxAÀ»xBµõ´a]°ß ¬iÂß ÷£õx u[PÐUS AÔÂ¨÷£õ® Gß£øu²® 
öu¶ÂzxUöPõÒQ÷Óõ®. 
 
 
 
Bµõ´a]¯õÍº øPö¯õ¨£®     £[÷PØ£õÍº øPö¯õ¨£® 
 
÷uv : 
 
 
  
 Bµõ´a] J¨¦uÀPiu® 
 
 
Bµõ´a] uø»¨¦ : AÀmµõ\Äsm £¶÷\õuøÚ _»® øuµõ´kPmiPÎß 
   ÁøPPøÍPshÔuÀ £ØÔ¯ B´Ä 
 
ö£¯º :       ÷uv : 
 
Á¯x :       EÒ ÷{õ¯õÎGs : 
 
£õÀ :       Bµõ´a] ÷\ºUøPGs : 
 
 C¢uBµõ´a]°ß ÂÁµ[PÐ® Auß ÷{õUP[PÐ® ¬Êø©¯õP GÚUS 
öuÎÁõP ÂÍUP¨£mhx. 
 
 GÚUS ÂÍUP¨£mhÂå¯[PøÍ {õß ¦¶¢x öPõsk {õßGÚx 
\®©uzøuzöu¶ÂUQ÷Óß. 
 
 C¢uBµõ´a]°À ¤Ó¶ß |º¨£¢uªßÔGß ö\õ¢u Â¸¨£zvß ÷£¶À uõß 
£[S ö£ÖQ÷Óß ©ØÖ® {õßC¢uBµõ´a]°¼¸¢x G¢÷{µ¬® ¤ßÁõ[P»õ® 
Gß£øu²® AuÚõÀG¢u £õv¨¦® HØ£hõx Gß£øu²® {õß ¦¶¢x öPõs÷hß. 
 
 {õßøuµõ´kPmi ÷{õ´PÒSÔzuC¢uBµõ´a]°ß 
ÂÁµ[PøÍUöPõshuPÁÀuõøÍ¨ ö£ØÖUöPõs÷hß. 
 
 {õßGßÝøh¯ _¯|øÚÄhß ©ØÖ® ¬Ê _u¢vµzxhßC¢u 
©¸zxÁBµõ´a]°À GßøÚ ÷\ºzxUöPõÒÍ \®©vUQ÷Óß. 
 
 GÚUS øuµõ´kAÀmµõ\Äsm £¶÷\õuøÚ ©ØÖ® ~s F] \øu 
£¶÷\õuøÚö\´x öPõÒÍ \®©u® öu¶ÂUQ÷Óß. 
 
 
 
øPö¯õ¨£® 
 
